: 1390

-1 45 .
. MRI .

(
(
(
( MCA
-2 70 .
110/80 140/90 .
.
( .
( .
( .
( .
-3 80 .
AF . 160/90
. .

( INR 2-3
(
( )( INR= 1,5-2
(

: 1390

-4 70 .
. TCD MCA
.

( )(DSA
( MCA
(
( MCA
-5 50 .
. 220/115 mmHg .
. ABG
.
. MCA .
tPA
( .
( .
( .
( .
-6 38 1/5 .
.
.
( MRI .
( Notch 3 .
( .
( .
-7 40 .
. 6 mm
. MRI .
(
( Clipping
( Coiling DSA
( Clipping DSA

: 1390

-8 60 .
%45 .

( MRA
(
(
( DSA
-9 35 3
. : 10
2 .
. .
ESR CSF MR . MRI
. DSA
) ( . .
. .

( .
( .
( .
( .

-10
( Sickle cell disease
( Moyamoya Vasculopathy
( Congenital heart disease
( Down's syndrome

-11 Fibrocartilagenous
( .
( .
( .
( .

: 1390

-12 -

( %30
( Glue
(
( 3

-13 CT

(
(
(
(

-14 56
. 2/5cm
.
( .
( .
( .
( .

-15 42
. .
LP CSF . .

(
(
( Brain MRI
( Brain CT angiography

-16 ) (ICH

( Charcot and Bouchard

(
( Lamina elastica
( Sub-intima

: 1390

-17 65
.
. .

( SPECT
(
(
( PET

-18 7
. :
( .
( .
( .
( .

-19 8
1/5-2/5 Spike wave . 10 (
(
(
(

-20 12 .
:
(
(
(
(

: 1390

-21

(
(
(
(

-22 30
. EEG .

(
(
(
(

-23 EEG 7 .

(
(
(

: 1390

-24 Red flag

( .
( .
( .
(

-25 25 .
.
( MRI
( CT
( CSF
(

-26 35 10 )(OCP
. OCP
(
(
(
(

-27 40 2
.
. . )(

(
(
(
(

-28 23 5-10 20
. .

(
(
(
( SUNCT

: 1390

-29 34 2 7 .
DTR Jaw Jerk . MRI
T2 5 1 .

( Aqua protein 4 .
( MS .
( LP OCB IgG Index .
( MS .

-30 M.S Delayed recovery

( Dissolution of cytokines
( PH Changes
( Remyelination
( Increased intermodal Sodium Channels

-31 M.S
( M.S
.
( Ejaculation .
( .
( INO MS SLE .

-32 :
( .
( .
( .
( .

-33 :
( 50-100ml .
( .
( Large- artery .
( SPECT .

: 1390

-34 47 AIDS .
.
. HIV .

( .
( HIV .
( CD4 .
( CSF .

-35
(
( down gaze paresis
(
(

-36 18 . .
Hirayama disease :
( C7-1.
( .
( SNAP .
( .

-37 CAG Kennedy

(
(
(
( .

-38 14 . .
6 . .
Aprataxin .
(
(
(
(

: 1390

-39 17 .
DTR . .
Square- wave jerk .
( .
( .
( .
( .

-40 10 .
. .
Optokinetic .
(
( .
( IgA .
( IgM .

-41
(
(
(
(

-42 45 6 .
.
.
( %50 .
( %90 .
( .
( .

-43 35 . flexor .
.
(
(
(
(

: 1390

-44 16
. . SNAP
. .
:
( .
( .
( .
(

-45 21 10
. NCV , EMG
. MRI BAEP .
.
( .
( .
( MP2 .
( .

-46 54 3 .
Supine .
. :
( .
( .
( .
( .

-47 12 .
.
. :
( 38 29 5 m/s .
( .
( 33 5
( .

: 1390

-48 Idiopathic Lumbosacral Plexopathy :

( .
( .
( EMG .
( IVIg .

-49 Lumbosacral Plexopathy

( .
( Panplexopathy L3 L1 .
( .
( .

-50 Inclusion body myositis :

( 50 .
( .
( .
( .

-51
( Perifascicular atrophy
( Endomysial inflammation
( Muscular microinfarction
( Tubuloreticular inclusions

-52 :
( %60-90 %72-95 .
( 10 .
( .
( .

-53 35 Mestinon 360 mg

100mg . 16 3
10 . 20
. .
( 150 mg
( 50mg
(
( Celcept

: 1390

-54 56 .
.
.
( .
( 1 .
( 50 .
( .

-55 50 5
. DTR
. wrist-drop

. . NC
:
Amplitude
)(mV

Latency
)(ms

NCV
)(m/s

12

Wrist

42

10/5

Elbow

20

Erb

( Amyotrophic lateral Sclerosis Rilutek .
( Multifocal motor neuropathy with conduction block IVIg .
( Kennedy CK .
( Late-onset SMA motor neuron 5q .

-56 ) (FSH
(
(
(
( dorsiflexor

: 1390

-57 45 3
.
DRT 3
.
( Neurodegeneration of brain due to Iron accumulation
( Bilateral striatopallidodentrate calcification
( Neuroacanthocytosis
( Progressive supranuclear plasy

-58 Exclusion criteria

(
( No-No
(
(

-59 45
. Rest .
. . Incontinence

DTR 3 . .

( Rarkin .
( MSA EMG .
( .
( EMG-NC .

-60 gait gait

( leg movements
( Initiation of walking
( postural reflexes
( steps

-61 10
.
(
(
(
(

: 1390

-62 47
.
. .
. .

( .
( . .
( .
( .

-63 15 Coordinated .

(
(
(
(

-64
(
(
(
(
-65
( Striatal hand
( Striatal foot
( Comptocormia
( Piza sign

-66 :

( Central apnea
( upper airway obstruction apnea
( Mixed apnea
( Apneustic breathing

: 1390

-67 35 Fluoxetine .
REM
30-40 Ictal EEG . .

( Periodic limb movement disorder
( Bruxism
( Nocturnal frontal lobe epilepsy
( Rhythmic movement disorder

-68 10 sleep walking . clonazapam 2mg

.
(
( Zolpidem
( Pramipexole
(
-69
( Non-REM I
( Non-REM III
( Non-REm IV
( REM

-70 27
LP 20cc . LP
CSF .

( Surgical treatment

( LP
( LP LP
(
-71 :
(
(
( Acute mountain sickness
(

: 1390

-72 ) (Disseminated

( General Paresis
( Tabes Dorsalis
( Syphilitic Gummas
( Cranial Neuropathis

-73 35
.

( MRI 3
(
(
(
-74 ) Epstein-Bar (EBV
( IgM ) (EBV CSF
( CSF
( CSF
( CSF
-75 7 ) (HSV1 Acyclovire .
CSF PCR .
.
( MRI
(
( Foscarnet
( Vidarabine
-76 HIV
( CD4 T cell
(
( cerebral vasculopathy
( basal ganglia calcification

: 1390

-77 47 meningoencephalitis HIV HAART

. Brain MRI
Enhancement .
)(HAART: Highly Active Antiretroviral Therapy
( HAART

(
( short course
( HAART
-78 54 HIV .
Brain MRI MRI

Ring

Enhancement .
( CSF
( Stereotactic Biopsy
( PCR JC Virus
( Toxoplasma Serology Testing

-79 27 .

. .

( (14-3-3 protein assay) CSF
( EEG

( MRI
( Lymph node Biopsy
-80 Tic Paralysis
(
(
(
( 2
-81 post stroke
(
(
(
(

: 1390

-82 76
. .
:
(
(
(
(
-83 :
(
(
(
(
-84 :
( Low grade
( grade
(
( ) (DVT
-85 56 complex partial seizure
.

(
(
(
( enzyme inducer
-86 8 ) (wide base Sunset sign
. ) (
.
(
(
(
(

: 1390

-87
( MRI
(
(
(
-88 4
. DTR
. Brain CT scan 1,5cm
. MRI Heterogeneous Enhancement.

( 3
(
(
( CSF
-89
(
(
(
( CSF
-90
( Limbic encephalopathy
( Cerebellar dysfunction
( Brainstem encephalopathy
( Autonomic nervous system dysfunction

-91 .
.
( Apperceptive visual agnosia
( Associative visual agnosia
( Optic Aphasia
( Prosopagnosia

: 1390

-92 40
.
.
.

(
( B12
( ) NO (
(
-93 ) (Mee's line
(
(
(
(
-94
(
(
(
(
-95 70
. 40 .
.
(
( Cooling
( Cooling
(
-96
(
( Rotational Chair
( Dix-Hallpike
( Epley

: 1390

-97
(
(
(
(
-98

( Ocular Bobbing
( Ocular Reverse Bobbing
( Ocular Inverse Bobbing
( Ocular Pseudobobbing

-99 ) (Postoperative

(
(
(
(
-100 42 2 .
.
: Jerk
. .
.
(
( -
(
(
-101 Delayed post-traumatic spinal cord syndrome :
( 5
( post traumatic
(
(

: 1390

-102 gait
(
(
( gait
(
-103 41
. MRI .
.
(
(
(
( L5
-104 74
.

(
(
(
(
-105 24 12
. .
. :
(
(
( MS MRI
(
-106 46 .
MRI . Bulging C6-C7 , C5-C6

.
(
( ALS
(
(

: 1390

-107 .
) (waiter's position .

( )(Avulsion

(
(
(
-108 45 .

(
( Viagra
( Yohimbin
( Droxidopa
-109 ) Postural Tachycardia syndrome (POSTS
:
(
(
(
(
-110 21
. 3
. .

(
(
(
(
-111 Cerebral Palsy
(
(
( 2000
(

: 1390

-112 50 . down gaze

Pursuit . .

( riMLF
( interstitial

(
(
-113 anterior inferior cerbellar
( Oscillopsia

(
(
(
-114 38 .

(
(
(
(
-115 III ) (BAEP
( Cochlear nucleus
( Superior olive
( Inferior colliculus
( Lateral leminiscus

-116 development
(
(
(
(

: 1390

-117 68 MI CPR

( Ping-Pong gaze

(
(
(
-118 4 6
EEG .
. LP CSF .

( High-dose ASA & a single dose of IVIg
( Full-dose IVIg
( Chemotherapy after Bone marrow aspiration
( Follow up without medication

-119
.
( Brain Spiral CT Scan
( Thyroid Function Tests
( EMG-NC studies
( Cerebral MRI

-120
( TTP
( DIC
( 20000
( Sickle Cell Disease
-121

. . .

(
( 4
(
( 4

: 1390

-122
( Junctional Scotoma
( Binasal Hemianopia
( Pseudobitemporal Hemianopia
( Incongruous Homonymous Hemianopia

-123 72
. . .

( Cerebral Angiography
( Cerebral MRI with contrast
( Electroretinoscopy
( Fluorescene angiography

-124 42
. .
.

( cerebral MRI
( Orbital MRI
( ESR & CT angiography
( Holter Monitoring

-125 64 .
. 8
.
( Progressive Supranuclear Palsy
( Diffuse Lewy Body Disease
( Idiopathic Parkinson Disease
( Multiple System Atrophy

-126
(
( superior oblique
( V
( V

: 1390

-127 Optic neuritis :

( Measles
( Rubella
( Varicella
( Mumps

-128 neuroimaging
( MRI T1-weighted
(
( MRI
( MRI
-129 Mitochondrial Encephalomyopathy, Lactic Acidosis

) and Stroke like Episodes (MELAS

(
(
(
(
-130 ) TGA (
(
(
(
(
-131 10 .
.
.
( EMG , NCV VEP

(
(
(

: 1390

-132 ) (withdrawal symptoms

) (
( -
( -
( -
(
-133 16
. .
.
(
(
(
(
-134 Simple Absence
(
(
(
(
-135 Dissociation Apraxia
( Postural
( Discrimination
( Movement
( Orientation

-136 ) (ICP ICP

( P1
( P2
( P3
( P4

: 1390

-137 20
. .
.
(
( -
(
(
-138 6 .
. .

(
( MRI
(
(
-139 35
. CT .

( %8-10
(
(
(
-140 ) (Suspended
(
(
(
(
-141 :
(
( MRI
(
(

: 1390

-142
. .
.
(
( MRI
(
(
-143 ) (FHM :
(
( FHM 1 spinocerebellar ataxia 6
( FHM 1 epileptic seizure
( FHM II ATP1 A2
-144 68 :
:
:
:
:
:
:
.
(
(
(
(
-145 :

)(Strain strangle


( Amyotrophic lateral sclerosis
( Primary lateral sclerosis
( Parkinson disease
( Myasthenia gravis

: 1390

-146
. EMG .
.
(
( Juvenile Parkinson disease
( Huntington chorea
( Multiple system atrophy
-147 47 :
:
:
:
:
:
:

( Acalculia
( Hemisensory loss
( Finger agnosia
( Right hemianopia

-148 12 case Tuberous sclerosis

.
. .
( cortical hamartomas

(
( Tuberous sclerosis
( subependymal giant cell astrocytomas
-149 ) visual evoked potential (VEP :
( VEP
( P100 latency
( %70-80 MS VEP
( pattern reversal VEP MS

: 1390

-150 54 . CT
. 3
Vegetative ICU .
(
(
(
(